Candriam S.C.A. Purchases 60,793 Shares of Dyne Therapeutics, Inc. $DYN
Candriam S.C.A. grew its holdings in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 13.1% during the second quarter, according to the company in its most recent filing with the...